The FDA granted Aardvark Orphan Drug Designation for the use of ARD-101 in Prader-Willi Syndrome (PWS), a rare genetic disease characterized by extreme and unabating […]
Agreement grants Eterna rights to license up to four next-generation iPS cell derived NK and T cell cancer therapies License terms include an upfront license […]